Cite
HARVARD Citation
Highland, K. et al. (n.d.). OP0242 SAFETY PROFILE OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS. Annals of the rheumatic diseases. p. 200. [Online].